BioAffinity Technologies Inc (BIAF) concluded trading on Wednesday at a closing price of $0.25, with 9.16 million shares of worth about $2.29 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -73.00% during that period and on June 18, 2025 the price saw a loss of about -6.55%. Currently the company’s common shares owned by public are about 28.46M shares, out of which, 20.25M shares are available for trading.
Stock saw a price change of -14.68% in past 5 days and over the past one month there was a price change of 11.58%. Year-to-date (YTD), BIAF shares are showing a performance of -72.41% which decreased to -87.44% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.16 but also hit the highest price of $2.99 during that period. The average intraday trading volume for BioAffinity Technologies Inc shares is 12.25 million. The stock is currently trading -12.88% below its 20-day simple moving average (SMA20), while that difference is down -28.93% for SMA50 and it goes to -72.23% lower than SMA200.
BioAffinity Technologies Inc (NASDAQ: BIAF) currently have 28.46M outstanding shares and institutions hold larger chunk of about 1.80% of that.
The stock has a current market capitalization of $7.15M and its 3Y-monthly beta is at 2.56. It has posted earnings per share of -$0.72 in the same period. It has Quick Ratio of 0.53 while making debt-to-equity ratio of 0.92. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BIAF, volatility over the week remained 5.34% while standing at 11.62% over the month.
Stock’s fiscal year EPS is expected to rise by 46.67% while it is estimated to increase by 55.00% in next year.
